M Withelder

Affiliations

Janssen Research & Development, Spring House.

Publications (1)

Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study.

Annals of oncology : official journal of the European Society for Medical Oncology

Avec: A Passaro , J Wang , Y Wang , S-H Lee , B Melosky , J-Y Shih , J Wang , K Azuma , O Juan-Vidal , M Cobo , E Felip , N Girard , A B Cortot , R Califano , F Cappuzzo , S Owen , S Popat , J-L Tan , J Salinas , P Tomasini , R D Gentzler , W N William , K L Reckamp , T Takahashi , S Ganguly , D M Kowalski , A Bearz , M MacKean , P Barala , A B Bourla , A Girvin , J Greger , D Millington , M Withelder , J Xie , T Sun , S Shah , B Diorio , R E Knoblauch , J M Bauml , R G Campelo , B C Cho , Auteur inconnu

Réseau de co-auteurs

J Wang 2 collaborations

A Passaro 1 collaboration

Y Wang 1 collaboration

S-H Lee 1 collaboration

B Melosky 1 collaboration

J-Y Shih 1 collaboration

K Azuma 1 collaboration

O Juan-Vidal 1 collaboration

M Cobo 1 collaboration

E Felip 1 collaboration

N Girard 1 collaboration

A B Cortot 1 collaboration

R Califano 1 collaboration

F Cappuzzo 1 collaboration

S Owen 1 collaboration

S Popat 1 collaboration

J-L Tan 1 collaboration

J Salinas 1 collaboration

P Tomasini 1 collaboration

R D Gentzler 1 collaboration

W N William 1 collaboration

K L Reckamp 1 collaboration

T Takahashi 1 collaboration

S Ganguly 1 collaboration

D M Kowalski 1 collaboration

A Bearz 1 collaboration

M MacKean 1 collaboration

P Barala 1 collaboration

A B Bourla 1 collaboration

A Girvin 1 collaboration

J Greger 1 collaboration

D Millington 1 collaboration

J Xie 1 collaboration

T Sun 1 collaboration

S Shah 1 collaboration

B Diorio 1 collaboration

R E Knoblauch 1 collaboration

J M Bauml 1 collaboration

R G Campelo 1 collaboration

B C Cho 1 collaboration

None None 1 collaboration